Sec Form 4 Filing - WEIL JOHN D @ ALLIED HEALTHCARE PRODUCTS INC - 2016-11-10

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
WEIL JOHN D
2. Issuer Name and Ticker or Trading Symbol
ALLIED HEALTHCARE PRODUCTS INC [ AHPI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
200 N BROADWAY SUITE 825
3. Date of Earliest Transaction (MM/DD/YY)
11/10/2016
(Street)
ST LOUIS, MO63102
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 107,154 D
Common Stock 5,000 I IRA
Common Stock 188,855 I Spouse ( 1 )
Common Stock 118,203 I Trust ( 2 )
Common Stock 15,853 I Corporation ( 4 )
Common Stock 239,587 I Trust ( 5 )
Common Stock 990,079 I Limited Partnership ( 3 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) $ 5.24 11/16/2007( 6 ) 11/16/2016 Common Stock 1,500 1,500 D
Option (right to buy) $ 6.73 11/08/2008( 6 ) 11/08/2017 Common Stock 1,500 1,500 D
Option (right to buy) $ 4.05 11/13/2009( 6 ) 11/13/2018 Common Stock 1,500 1,500 D
Option (right to buy) $ 5.04 11/13/2010( 6 ) 11/13/2019 Common Stock 1,500 1,500 D
Option (right to buy) $ 4.34 11/11/2011( 6 ) 11/11/2020 Common Stock 1,500 1,500 D
Option (right to buy) $ 3.555 11/10/2012( 6 ) 11/10/2021 Common Stock 1,500 1,500 D
Option (right to buy) $ 2.59 11/08/2013( 6 ) 11/08/2022 Common Stock 1,500 1,500 D
Option (right to buy) $ 2.31 11/14/2014( 6 ) 11/14/2023 Common Stock 1,500 1,500 D
Option (right to buy) $ 1.58 11/13/2015( 6 ) 11/13/2024 Common Stock 1,500 1,500 D
Option (right to buy) $ 1.17 11/12/2016( 6 ) 11/12/2025 Common Stock 1,500 1,500 D
Option (right to buy) $ 1.13 11/10/2016 A 1,500 11/10/2017 11/10/2026 Common Stock 1,500 ( 6 ) 1,500 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
WEIL JOHN D
200 N BROADWAY SUITE 825
ST LOUIS, MO63102
X X
Signatures
John D. Weil 11/14/2016
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The reporting person disclaims any economic benefit in such shares.
( 2 )Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
( 3 )Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares reported includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).
( 4 )Owned by a corporation controlled by the reporting person.
( 5 )Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares.
( 6 )Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.

Remarks:
Since the reporting person's last Form 4 filing, the reporting person resigned as a co-trustee of a trust for the benefit of a sibling, for which the reporting person previously reported beneficial ownership of 447,361 shares.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.